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Abstract A novel 28 kDa glycoprotein was purified from 
exocytosed material from human nentrophils and its primary 
structure partially determined. Degenerate oligonucleotide pri- 
mers were used to amplify cDNA clones from a human bone 
marrow cDNA library. The deduced 245 amino acid sequence of 
the 2124 bp full-length cDNA showed high degrees of similarity 
to the deduced sequences of the human gene TPX-1 and of sperm 
coating glycoprotein from rat and mouse. Subcellular fractiona- 
tion of human neutrophils indicated that the protein is localized 
in specific granules. The protein was named SGP28 (specific 
granule protein of 28 kDa). 
Key words: TPX-1; Acidic epididymal glycoprotein; Patho- 
genesis related protein 1; Subcellular fractionation 
2. Materials and methods 
2.1. Purification of SGP28 
Isolated neutrophils were resuspended in Krebs-Ringer phosphate 
at approximately 5 x 108 cells/ml and preincubated at 37°C for 5 min. 
Phorbol myristate-acetate (PMA, Sigma) was added at 5 ~tg/ml and 
the neutrophils stimulated for 20 min. Protease inhibitors were added 
(phenylmethylsulfonylfluoride (1 mM), aprotinin (200 KIE/ml), pep- 
statin (1 mM)) and the cells pelleted by centrifugation. After precipi- 
tation in 18% PEG, removal of PEG from non-precipitated proteins 
by addition of 0.5 M K2HPO4, and a change of buffer to 0.05 M 
sodium acetate, the PEG supernatant was subjected to cation ex- 
change-chromatography on Mono S using FPLC (Pharmacia) (all 
procedures as described in [8]). Fractions containing SGP28, as eval- 
uated by SDS-PAGE, were pooled and re-chromatographed on
MonoS and the eluate subjected to gel filtration on Superose 12 
(Pharmacia), using 25 mM Tris-HCl, pH 8.0, 100 mM NaC1 as buffer. 
I. Introduction 
The neutrophil is equipped with a huge number of granules 
in addition to the highly mobilizable secretory vesicles (for 
review see [1]). Granules can be divided into peroxidase posi- 
tive, azurophil granules and peroxidase negative granules, of 
which the latter encompass pecific granules and gelatinase 
granules [2,3]. These granules are mobilized in a sequential 
order [4]. Exocytosis is an important aspect of neutrophil 
function. Peroxidase negative granule proteins like collagenase 
and gelatinase indirectly contribute to the microbicidal poten- 
tial of the neutrophil by degrading extracellular matrix, thus 
allowing migration of the cell in tissues [2,3,5]. Other matrix 
proteins are directly involved in the killing of microorganisms, 
exemplified by cathepsin G, azurozidin, defensins, and bacter- 
icidal/permeability increasing protein, all of which are located 
in azurophil granules [1,6]. A novel microbicidal protein 
hCAP-18 has recently been identified in specific granules [7]. 
The identification and characterization of novel matrix pro- 
teins and the determination of their subcellular localization is 
therefore crucial for the understanding of the diversity of 
neutrophil function. 
We here describe the isolation and partial amino acid se- 
quence of a novel 28 kDa protein (SGP28), its cDNA se- 
quence, and its subcellular localization in specific granules 
of human neutrophils. 
*Corresponding author. Fax: (45) 3545 4371. 
The cDNA sequence has been submitted to EMBL and has been 
given the accesion umber X94323. 
2.2. Endoglucosidase tr atment 
SGP28 was incubated with either N-glycanase (10 U/ml), O-glyca- 
nase (50 mU/ml) or endoglycosidase H (0.25 U/ml) as previously 
described [9]. Glucosidases were obtained from Genzyme. 
2.3. Structural nalysis 
Tryptic peptides were obtained by incubation of the reduced and 
carboxyamidomethylated protein with trypsin as described [8]. The 
peptides were purified on reversed phase HPLC using a Vydac Cs 
column (2.1 x150 mm) and eluted at 0.2 ml/min with a gradient 
from 0.1% trifluoroacetic acid in water to 0.1% trifluoroacetic acid 
in acetonitrile (0.5%/min). Molecular masses of individual fragments 
were determined by laser desorption mass spectrometry performed in 
a Biflex instrument (Bruker-Franzen) using c~-cyano-4-hydroxy-cin- 
namic acid as matrix. The intact protein and the tryptic peptides 
were subjected to amino acid sequence analysis using an automatic 
protein sequencer (Procise, Applied Biosystems). 
2.4. Cloning and sequencing ofSGP28 cDNA 
Two degenerate primers were designed from the partial amino acid 
sequence of SGP28 to fit the regions coding for amino acids 55-60 
(PPARNM: 5'-CCICCIGCI(A/C)GIAA(C/T)ATG-3')and 171 178 
(YCPAGNWA: 5'-GCCCA(A/G)TTICCIGCIGG(A/G)CA(A/ 
G)TA-3'). The two primers were used for PCR amplification from a 
human bone marrow cDNA library (Clontech) with Taq polymerase 
(Promega). The amplified fragment was cloned in the plasmid vector 
pCR II using the TA cloning kit (Invitrogen) and the insert of one 
clone sequenced with the Sequenase kit (Amersham). From this se- 
quence, two specific primers were designed to amplify the 5' and 3' 
region of SGP28. The 5' region of SGP28 was amplified from a hu- 
man bone marrow cDNA library with the thermostable proofreading 
polymerase Pwo (Boehringer-Mannheim) using a primer covering nu- 
cleotides 279 299 (5'-GGTTACTGTGTCTGTAATTGC-3') and a 
vector specific primer. The amplification fragment was cloned in 
pCR II and two clones sequenced. For amplification of the 3'-region, 
a primer covering nucleotides 226-246 (5'-GATGGAATGGAA- 
CAAAGAGGC-3') and a vector specific primer was used. Taq poly- 
merase was used (as Pwo failed) for amplification from the human 
bone marrow cDNA library. The amplification fragment was cloned 
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Fig. 1. SDS-PAGE protein profiles during purification and deglyco- 
sylation of SGP28. Upper panel (non-reducing conditions): material 
exocytosed by PMA (lane 1); PEG-supernatant (lane 2); SGP28- 
containing fractions after chromatography on MonoS (lane 3); pure 
SGP28 after gel filtration on Superose 12 (lane 4); Western blotting 
of purified SGP28 with antibodies against a synthetic SGP28 dode- 
capeptide (lane 5). Lower panel (reducing conditions): samples of 
purified SGP28 were incubated with either buffer (lane 1), N-glyca- 
nase (lane 2), O-glycanase (lane 3) or endoglycosidase H (lane 4). 
in pCR II and three clones sequenced. All clones were sequenced in 
both directions. 
2.5. Generation of anti-peptide antibodies 
A peptide (ELRRAVSPPARNC) corresponding to a part of the 
amino-terminal sequence extended with Cys and covalently coupled 
to BSA, was purchased from Kem-En-Tec (Copenhagen, Denmark). 
Immunization of rabbits was carried out by Dako (Glostrup, Den- 
mark). 
2.6. Subcellular fractionation 
Fractionation was performed as described [3]. In short, diisopropyl- 
fluorophosphate (5 mM) treated neutrophils were disrupted by nitro- 
gen cavitation at 0.5-1 × 108/ml. The postnuclear supernatant (10 ml) 
was applied on a three-layer Percoll density gradient and centrifuged 
----} 
Fig. 2. cDNA and amino acid sequence of SGP28. The cDNA se- 
quence is given as determined from clones with overlapping se- 
quence. The deduced amino acid sequence is shown below the nu- 
cleotide sequence. The amino acids identified by sequencing of the 
N-terminus and of tryptic peptides of the protein are given in bold 
and individual fragments marked by brackets. Nucleotide sequence 
variation was observed at 10 positions. The nucleotide only ob- 
served in one of the three clones is shown above the sequence. One 
of the three clones had an additional A at position 1603 (*) and a 
C at the very Y-end instead of TG (##). The poly(A) signal and 
the asparagine of the N-glycosylation site (position 239) are under- 
lined. 
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at 37,600 Xg for 30 min. The gradient was fractionated and fractions 
assayed for myeloperoxidase, lactoferrin, gelatinase, latent alkaline 
phosphatase, and HLA. Except for the enzymatic assay for alkaline 
phosphatase, all markers were measured by ELISA [3]. For Western 
blotting of subcellular fractions, Percoll was removed from 800 gl of 
each fraction by ultracentrifugation, and the biological material re- 
suspended in 200 gl PBS. 
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2. 7. SDS-PAGE and Western blotting 
SDS-PAGE and Western blotting were performed largely as de- 
scribed by Laemmli and Towbin, respectively [10,11]. The nitrocellu- 
lose sheets were blocked for 1 h in 5% skim milk. The antiserum 
against he SGP28-peptide-BSA was preincubated for at least 2 h in 
PBS containing 0.5% BSA. Color was developed by the metal-en- 
hanced DAB-chromogen (Pierce). 
3. Results and discussion 
SGP28 was purified from exocytosed material from PMA- 
stimulated human neutrophils. The purification involved 
PEG-precipitation of exocytosed proteins followed by ca- 
tion-exchange chromatography of non-precipitated protein. 
Eluates containing SGP28 were finally subjected to gel-filtra- 
tion on Superose 12. SDS-PAGE of the different purification 
steps is shown in Fig. 1. The purified protein was reduced and 
denaturated by boiling in SDS and [3-mercaptoethanol f l- 
lowed by incubation in the presence of buffer or either one 
of the endoglycosidases N-glycanase, O-glycanase, or Endo- 
glucosidase H (Fig. 1). The reduction of SGP28 resulted in a 
shift in mobility from 28 kDa to approximately 30 kDa. 
Furthermore, treatment with N-glycanase resulted in reduc- 
tion of the apparent molecular mass of the protein from 30 
kDa to approximately 27 kDa, whereas the other glucosidases 
had no significant effect (Fig. 1). This indicates the presence of 
one or more complex N-linked oligosaccharide side chains in 
SGP28. 
In order to identify the protein, the amino acid sequences of 
the amino-terminus and of several tryptic fragments were de- 
termined as shown in brackets in Fig. 2. Based on these amino 
acid sequences two degenerate oligonucleotide primers were 
used for PCR amplification of a human bone marrow 
cDNA library resulting in a 350 bp product. From its se- 
quence, two specific primers were designed to amplify the 5' 
and 3' region of SGP28. Two clones covering the 5' region (nt 
1-299 and 3-299) showed complete identity in the overlapping 
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Fig. 3. Subcellular localization of SGP28. Isolated, disrupted neutrophils were applied on a three layer Percoll-density gradient, which was cen- 
trifuged and fractionated. Fractions were assayed for the following marker proteins as shown in the upper panel: myeloperoxidase (MPO, azur- 
ophil granules), lactoferrin (specific granules), gelatinase (gelatinase granules), latent alkaline phosphatase (secretory vesicles), and HLA (plasma 
membranes). The lower panel shows Western blotting of subcellular f actions with the antibodies against he synthetic SGP28-peptide. No reac- 
tivity was observed in fractions 1 through 7 and 20 through 27 (not shown). The distribution profile of values for densitometric s ans of each 
fraction are shown in the upper panel (SGP28). 
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sequence. Comparison of three clones of the Y-region (all 
three from nt 271-2124) showed sequence variations at 10 
positions probably due to misincorporated nucleotides during 
the PCR reaction (Fig. 2). Furthermore, one of the clones 
differed by both having an additional A at position 1603 
and by having a C at the very 3'-end of the transcript (before 
the poly(A) tail) instead of TG. The full-length cDNA se- 
quence of 2124 bp is shown in Fig. 2. It has an open reading 
frame of 735 bp encoding a protein of 245 amino acid resi- 
dues. One potential N-glycosylation site was identified at as- 
paragine residue 239 (underlined in Fig. 2), in accordance with 
the deglycosylation data presented above. The first 19 amino 
acids fulfill the criteria for a consensus equence of a signal 
peptide according to von Heijne [12]. According to this, the 
amino-terminal (residue 20 in Fig. 2) of the 226 amino acid 
mature protein of 27.6 kDa is alanine. However, the amino- 
terminal amino acid of the purified protein is threonine (re- 
sidue 33 in Fig. 2), but the deduced amino acid sequence 
preceding this threonine contains several charged residues 
(the sequence NEDKDP, amino acids 21-26 in Fig. 2). 
Thus, the amino acids at position 32/33 are unlikely as a 
cleavage site for a signal peptide, according to the rules of 
von Heijne [12]. This indicates a post-translational N-terminal 
trimming of the protein by 13 amino acids, either by proteo- 
lysis during purification, or prior to packaging in granules. 
The identical mobility of the purified SGP28 and SGP28 pre- 
sent in subcellular fractions of specific granules (both migrate 
at 30 kDa under reducing conditions as detected by Western 
blotting, see below), suggests N-terminal trimming prior to 
arrival in specific granules as the most likely event. To the 
authors knowledge, the existence of proforms of specific gran- 
ule proteins has not been described previously, whereas this is 
a well known phenomenon for many azurophil granule pro- 
teins [6]. 
For subsequent determination of the subcellular localiza- 
tion in human neutrophils of SGP28, antibodies were raised 
against a synthetic dodecapeptide (ELRRAVSPPARNC) cor- 
responding to amino acids 48-59 of SGP28 (Fig. 2) extended 
with Cys. The anti-peptide antibodies recognized the purified 
SGP28 as evidenced by Western blotting (Fig. 1, upper panel). 
Subcellular fractionation of isolated, disrupted neutrophils 
was performed on a three-layer Percoll density gradient, 
which resolves all known mobilizable organelles, including 
azurophil, specific, and gelatinase granules in addition to se- 
cretory vesicles. Fig. 3 shows the distribution of marker en- 
zymes for these subsets. Western blotting of subcellular frac- 
tions with anti-SGP28 antibody (under reducing conditions) 
revealed a dominating band at 30 kDa and a minor 28 kDa in 
fractions 8 through 16, peaking in fractions 10 and 11. This 
distribution profile is similar to that of lactoferrin as demon- 
strated by the colocalization of the profiles of lactoferrin de- 
termined by ELISA and the values of the densitometric s an 
TPX- I  MALL  PV- LFLVTVLL  P S L - -  PA-  EGKD PAFTALLTTQLQVQRE I VNKHN ELRKAVS P PASNMLKMEWS RE 66 
I I il lliE 1111 II I l i l f l l l l f l l l  l i l t l l l l I l l I l l  I I I l i l  I I I i i i i  1 
SGP28 MT L FPVLL  FLVAGL L P S F- -  PANEDKD PAFTALLTTQTQVQRE I VNKHNELRRAVS P PARNMLKMEWN KE 68 
] I III I I I I II i f II Jl li fill lii III I II 
SCG MALMLVLLFLAAVLP  P S LLQDTTDEWDRDLENLSTTKLSVQEE I I NKHNQLRRTVS P S GS DLLRVEWDHD 70 
TPX- I  VTTNAQRWANKCTLQHSDP EDRKT STRCGENLYMS S DPTSWS SA IQSWYDEI  LDFVYGVGP KS PNAWGH 136 
11i ili i li I ii ii l l l l l i l i l  I ill i l l I i It II l lffl i l l l l l l  
SGP28 AAANAQKWANQCNYRH SN P KDP/~IT S LKCGENLYMS SAP S SWSQAI  QSW FDEYND FD FGVG P KT PNAWGH 138 
i l l i l l i l  f i II I i f l i t111 I I III fl I II II It lii llJ 
SCG AYVNAQ KWANRC I YNH S P LQHRTTTLKCGENLFMAN Y PASW S SVI QDWY DES LD FVFG FG P KKVGVKVGH 140 
* * * * * * * * * 
TPX- I  YTQLVWYSTYQVGCGIAYCPNQDSLKYYYVCQYCPAGNNMNRKNT PYQQGT PCAGCPDDCDKGLCTNSCQ 206 
Ill llll i lill I I I I I I  l l i l f l l l l l i l i l  II tl If III ill fl l l l l i I 
SGP28 YTQVVWYS S YLVGCGNAYC PNQKVLKYYYVCQYC PAGNWANRLYVPYEQGAP CAS C PDN C DDGLCTN GCK 208 
l l i i l l  I ]I II i Jl i ill lii ill l Ill il I il ill II i i l l I l  I 
SCG YTQVVWN ST FLVACGVAECPDQP-  LKYFYVCHYCPGGNYVGRLYS PYTEGEPCDSC PGNCEDGLCTN SCE 209 
* * * * * 
TPX- I  YQDLLSNCDS LKNTAGCEHELLKEKCKATCLCENKI  Y 243 
] 11 Jil lil i I i } Ill I I I il 
SGP28 YEDLYSNCKS LKLTLTCKHQLVRDSCKAS CNCSNS I Y 245 
III llfi II I L I Ill I I 
SCG YEDNYSNCGDLKKMVSCDDPLLKEGCRASCFCEDKI  H 246 
PRlb  .... AAVGVGAVSWSTKLQAFAQNYANQRINDCKLQHS .... 73 
I I i li ill 
SGP28 E IVNKHNELRRAVSP . . . . . . . . . . . .  PARNMLKMEWNKEAAANAQKWANQCNYRHSNPKD .... 88 
IL li i I II i[ il I i II II i i i I 
VVA5 E ILKRHNDFRQNVAKGLETRGKPGPQPPAKNMNVLVWNDELAKIAQTWANQCDFNHDDCRN .... 103 
PR Ib  VN SWVS E KKDYDYGSNTCAAGKV-  CGHYTQVVWRAS T S I GCARVVCNNN RGVFI  T CNYEPRGNIVG.  . 136 
II I I l I i i ] f i l l l L  i II I I i I I il 
SGP28 I Q SW FDEYN D FD FGVG P KT PNAV-VGHYTQVVWYS S YLVGC GNAYC pNQKVLKYYYVCQYC PAGNWAN . . 179 
I I li I 11 i l i i l i l  II ILl i If I l 11 I 
VVA5 I KQWEDEVTEFNYKVGLQNSNFRKVGHYTQMVWGKTKEI  GCGSI  KYI EDNWYTHYLVCNYGPGGNDFN. .  198 
Fig. 4. Alignment of SOP28 with TPX-I (human), sperm coating glycoprotein (SCG, rat), vespid venom antigen 5 (VVA5), and pathogenesis 
related protein lb (barley) (PRIb). The aligned sequences are all deduced from cDNA sequences [13,14,18,19]. Vertical ines mark identical ami- 
no acids. Alignment of part of SGP28 with PRlb and VAA5 is shown in the lowest part of the figure. Conserved cysteine residues are marked 
by asterisks. The N-terminal amino acids, following the putative cleavage sites of the signal peptides (as suggested in the references given 
above) are shown in bold. 
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of the immunoblotting for SGP28 (Fig. 3). This indicates 
SGP28 to be a constituent of specific granules. The presence 
of the 28 kDa band could be caused by limited proteolysis of 
the major 30 kDa band. Since the protein was isolated from 
material exocytosed by PMA it is most likely a matrix protein. 
This is further corroborated by the lack of membrane span- 
ning sequences in the deduced sequence of the protein. We 
suggest the protein be named SGP28 (specific granule protein 
of 28 kDa). 
In the sequence similarity search, SGP28 was found to be 
highly similar to the deduced amino acid sequences of the 
cDNAs of the testis-specific human gene TPX-1 [13] and of 
an androgen-dependent sperm coating glycoprotein (also 
known as protein DE and acidic epididymal glycoprotein 
(AEG)) from mouse and rat epididymis [14,15], with 72.4 
and 55% identical amino acids, respectively (Fig. 4). TPX-1 
and sperm coating glycoprotein were previously concluded to 
be highly similar but distinct proteins belonging to a novel 
gene-family [13]. Our findings indicate that SGP28 is a new 
member of this gene family. By Northern blotting, AEG and a 
highly similar AEG-2 have been demonstrated in the mouse 
submandibular gland, where the transcription is androgen-de- 
pendent [16]. It remains to be established whether the expres- 
sion of SGP28 is influenced by androgens. 
SGP28, TPX-1 and sperm coating glycoprotein are very 
rich in cysteines, especially in the carboxy-terminal third of 
the proteins (marked by asterisks in Fig. 4). This is a char- 
acteristic feature of several natural antibiotic peptides [17]. All 
of these residues have been conserved from the rodent sperm 
coating glycoprotein and Tpx-1 to the human proteins TPX-1 
and SGP28. These cysteines could potentially form intramo- 
lecular disulfide bridges, which is in accordance with the di- 
minished mobility of reduced SGP28 compared to the unre- 
duced form, when visualized by SDS-PAGE (Fig. 1). 
In the alignment studies, pathogenesis related protein 1 
from various plants and the vespid venom antigen 5 showed 
significant similarity to part of SGP28 (Fig. 4). From the 
alignment of SGP28 with pathogenesis related protein lb 
from barley [18], venom antigen 5 from the white face hornet 
[19], TPX-1 and sperm coating glycoprotein, it is observed 
that the amino acid sequence GHYTQVVW (residues 137- 
144 in SGP28, Fig. 4) is a particularly well preserved region 
in all the identified proteins, indicating an important func- 
tional role of this domain. While the functions of TPX-1 
(not yet isolated as a protein) and vespid venom antigen 5 
are unknown, pathogenesis related proteins constitute a large 
family of plant proteins, whose synthesis is known to be in- 
duced upon infection. This suggests a role for these proteins in 
the host defense of plants [20]. In support of this notion, the 
pathogenesis related protein P14 from tomato exhibited anti- 
fungal activity in vitro [21]. Sperm coating glycoprotein is 
known to associate with the acrosomal region of spermatozoa 
after secretion from the epididymis [22]. Antibodies against 
the protein were able to block fertilization of an ovum [23], 
indicating a role for sperm coating glycoprotein i  the pene- 
tration by spermatozoa of the extracellular matrix-like zona 
pellucida, which surrounds the ovum. A role of SGP28 in 
degradation of the extracellular matrix during neutrophil mi- 
gration is possible and suggested by its localization in specific 
granules, where other matrix degradative enzymes are stored 
[1-3,5]. The elucidation of the potential anti-microbial and 
matrix-degradative actions of SGP28 awaits its recombinant 
production. 
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